» Articles » PMID: 26729619

Evaluation of Post Cessation Weight Gain in a 1-Year Randomized Smoking Cessation Trial of Electronic Cigarettes

Overview
Journal Sci Rep
Specialty Science
Date 2016 Jan 6
PMID 26729619
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Stop smoking it is often associated to weight gain that is one of the most important causes for relapse. This is the first study to describe long-term changes in body weight in smokers invited to quit or reduce smoking by switching to ECs. Conventional cigarettes consumption and body weight were measured prospectively in a randomized controlled trial of smokers invited to switch to ECs. Post cessation weight changes from baseline at week-12, -24 and -52 were compared among 1) high, medium and zero nicotine strength products and 2) pooled continuous smoking failure, smoking reduction and abstinence phenotypes. Saliva cotinine levels and appetite levels were also measured. No significant changes in body weight were observed among high, medium and zero nicotine strength products. Differences among continuous smoking phenotypes were significant only at week-12 (p = 0.010) and week-24 (p = 0.012) with quitters gaining 2.4{plus minus}4.3 Kg and 2.9{plus minus}4.4 Kg respectively. However, weight gain at week-52 (1.5{plus minus}5.0 Kg) was no longer significant compared to Failures and Reducers. No confounding factors could explain the significant changes in body weight. Smokers who quit smoking by switching to ECs may limit their post-cessation weight gain, with substantial reversal in weight gain being manifest at late time points.

Citing Articles

Electronic cigarettes for smoking cessation.

Lindson N, Butler A, McRobbie H, Bullen C, Hajek P, Wu A Cochrane Database Syst Rev. 2025; 1:CD010216.

PMID: 39878158 PMC: 11776059. DOI: 10.1002/14651858.CD010216.pub9.


e-Cigarettes, Smoking Cessation, and Weight Change: Retrospective Secondary Analysis of the Evaluating the Efficacy of e-Cigarette Use for Smoking Cessation Trial.

Lyzwinski L, Dong M, Wolfinger R, Filion K, Eisenberg M JMIR Public Health Surveill. 2024; 10:e58260.

PMID: 39283667 PMC: 11443201. DOI: 10.2196/58260.


Effectiveness of e-cigarettes as a stop smoking intervention in adults: a systematic review.

Vyas N, Bennett A, Hamel C, Beck A, Thuku M, Hersi M Syst Rev. 2024; 13(1):168.

PMID: 38951828 PMC: 11218295. DOI: 10.1186/s13643-024-02572-7.


Electronic cigarettes for smoking cessation.

Lindson N, Butler A, McRobbie H, Bullen C, Hajek P, Begh R Cochrane Database Syst Rev. 2024; 1:CD010216.

PMID: 38189560 PMC: 10772980. DOI: 10.1002/14651858.CD010216.pub8.


Varenicline and counseling for vaping cessation: a double-blind, randomized, parallel-group, placebo-controlled trial.

Caponnetto P, Campagna D, Ahluwalia J, Russell C, Maglia M, Riela P BMC Med. 2023; 21(1):220.

PMID: 37403047 PMC: 10321010. DOI: 10.1186/s12916-023-02919-2.


References
1.
Ussher M, Taylor A, Faulkner G . Exercise interventions for smoking cessation. Cochrane Database Syst Rev. 2014; (8):CD002295. DOI: 10.1002/14651858.CD002295.pub5. View

2.
Etter J, Bullen C . Saliva cotinine levels in users of electronic cigarettes. Eur Respir J. 2011; 38(5):1219-20. DOI: 10.1183/09031936.00066011. View

3.
Jeffery R, Hennrikus D, Lando H, Murray D, Liu J . Reconciling conflicting findings regarding postcessation weight concerns and success in smoking cessation. Health Psychol. 2000; 19(3):242-6. DOI: 10.1037//0278-6133.19.3.242. View

4.
Wall M, Johnson J, Jacob P, Benowitz N . Cotinine in the serum, saliva, and urine of nonsmokers, passive smokers, and active smokers. Am J Public Health. 1988; 78(6):699-701. PMC: 1350288. DOI: 10.2105/ajph.78.6.699. View

5.
Stewart S, Cutler D, Rosen A . Forecasting the effects of obesity and smoking on U.S. life expectancy. N Engl J Med. 2009; 361(23):2252-60. PMC: 4394736. DOI: 10.1056/NEJMsa0900459. View